Research Article
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2– Metastatic Breast Cancer
| | American Association for Cancer Research (AACR) (2014-2019) | “hormone receptor positive” OR “HR+” OR “ER+” OR “PR+” OR “estrogen receptor positive” | | American Society of Clinical Oncology (ASCO) Breast Cancer Symposium (2014-2018) | breast cancer AND (“hormone receptor positive” OR “HR+” OR “ER+” OR “PR+” OR “estrogen receptor positive”) | | San Antonio Breast Cancer Symposium (2014-2018) | breast cancer AND (“hormone receptor positive” OR “HR+” OR “ER+” OR “PR+” OR “estrogen receptor positive”) | | European CanCer Organisation (ECCO) (2015-2016) | breast cancer AND (“hormone receptor positive” OR “HR+” OR “ER+” OR “PR+” OR “estrogen receptor positive”)
Abstract title: breast cancer | | European Society for Medical Oncology (ESMO) (2014, 2016) | breast cancer AND (“hormone receptor positive” OR “HR+” OR “ER+” OR “PR+” OR “estrogen receptor positive”)
Abstract title: breast cancer |
|
|
